|
1） |
Kawai S, Takeuchi T, Yamamoto K, Tanaka Y, Miyasaka N. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs；A multicenter, double-blind, parallel-group trial. Mod Rheumatol. 2011 Oct；21 (5)：456-468. |
|
2） |
Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis；A randomized, double blind, placebo controlled dose-finding study. J Rheumatol. 2004 Feb；31 (2)：243-251. |
|
3） |
Kawai S, Hashimoto H, Kondo H, Murayama T, Kiuchi T, Abe T. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. J Rheumatol. 2006 Nov；33 (11)：2153-2161. |
|
4） |
Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis；A double-blind trial. Arthritis Rheum. 2003 Dec；48 (12)：3328-3337. |
|
5） |
Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate；A six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum. 2002 Aug；46 (8)：2020-2028. |
新検索ページはこちら
ログイン
お問い合わせ
書誌情報
